Recent Finacing
Recent Raise
Afferent Pharmaceuticals is a clinical-stage biotech developing selective P2X3 antagonists such as oral AF-219 for pathologic cough, with programs targeting IPF cough, respiratory disorders, visceral pain, and hypertension.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors